Research Topics
| J P GregoireSummaryCountry: Canada Publications
| Collaborators
|
Detail Information
Publications
Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decisionmaking framework to growth hormone for Turner syndrome patientsMireille M Goetghebeur
BioMedCom Consultants Inc, Dorval, Quebec, Canada
Cost Eff Resour Alloc 8:4. 2010..Further testing and validation is needed to build up MCDA approaches combined with pragmatic HTA in healthcare decisionmaking...- Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in QuebecAlain Vanasse
Department of Family Medicine, Faculty of Medicine, Universite de Sherbrooke, 3001 12th Avenue North, Sherbrooke QC, J1H 5N4, Canada
BMC Musculoskelet Disord 6:33. 2005..In this study, we identified potential predictors of bone mineral density (BMD) testing and OP treatment, which include place of residence... - Spatial variation in the management and outcomes of acute coronary syndromeAlain Vanasse
Family Medicine Department, Faculty of Medicine, Universite de Sherbrooke, 3001, 12th Avenue North, Sherbrooke QC, Canada, J1H 5N4
BMC Cardiovasc Disord 5:21. 2005..We also assessed whether there was a relationship between ICP and HD, LoS, and EHR, and if the relationships varied spatially... 
Choice of initial antihypertensive medication and continuation of useJ P Gregoire
Faculte de Pharmacie, Cite Universitaire, Quebec, Canada
Can J Cardiol 15:39F-41F. 1999..More research designed to assess the effectiveness of treatments in real life situations is needed. In particular, there is a need to clarify the role of side effects on continuation of initial treatment...- Predictors of self-reported noncompliance with antihypertensive drug treatment: a prospective cohort studyJ Gregoire
Faculty of Pharmacy and Population Health Research Unit, Universite Laval, Quebec, Canada
Can J Cardiol 22:323-9. 2006..Persistence and compliance are different aspects of the broader concept of adherence to drug treatment. In a prior study, determinants of nonpersistence in a group of patients newly prescribed antihypertensive medications were examined... - Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental studyJean Pierre Grégoire
Population Health Research Unit, Centre Hospitalier Affilie Universitaire De Quebec, 1050 Chemin Ste Foy, Quebec, QC, G1S 4L8, Canada
BMC Health Serv Res 6:33. 2006..However, there is little evidence of their effectiveness. The objective of this study was to assess the impact of both a retrospective and a concurrent DUR programs on the quality of in-hospital prescribing... 
Persistence patterns with oral antidiabetes drug treatment in newly treated patients--a population-based studyJean Pierre Grégoire
Faculty of Pharmacy, Universite Laval, Quebec, QC, Canada
Value Health 13:820-8. 2010..We assessed persistence patterns with oral antidiabetes drug (OAD) in patients newly dispensed with different OAD classes...- Tolerability of antihypertensive drugs in a community-based settingJ P Gregoire
Epidemiology Research Group and Faculty of Pharmacy, Laval University, Quebec City, Quebec, Canada
Clin Ther 23:715-26. 2001..Outside the experimental environment of clinical trials, the tolerability of angiotensin-converting enzyme inhibitors (ACEIs), calcium channel blockers (CCBs), and the angiotensin II antagonist losartan has not been compared... - Appropriateness of omeprazole prescribing in Quebec's senior populationJ P Gregoire
Faculté de Pharmacie et Groupe de recherche in epidémiologie, Universite Laval, Quebec
Can J Gastroenterol 14:676-80. 2000..In July 1993, the Quebec drug program listed omeprazole, with restriction, in its formulary. On January 1, 1994, this restriction was lifted; since then, omeprazole has been listed in the regular provincial formulary... - Inter-provincial variation in government drug formulariesJ P Gregoire
Faculte de Pharmacie, Groupe de Recherche en Epidemiologie, Universite Laval, Quebec
Can J Public Health 92:307-12. 2001..There is a wide variation across provinces in terms of NDM listed in the formularies. This variation reflects inter-provincial differences in the way drugs are selected for coverage... - Health-related quality of life in hypertension: impact of a pharmacy intervention programmeI Cote
Population Health Research Unit, Faculty of Pharmacy, Universite Laval, Quebec, QC, Canada
J Clin Pharm Ther 30:355-62. 2005..The objective of the present study was to assess the effect of this pharmacy programme on the health-related quality of life (HRQOL) of individuals treated for hypertension... - Underuse of cardioprotective treatment by the elderly with type 2 diabetesC Sirois
Faculty of Pharmacy, Universite Laval, Quebec, Canada
Diabetes Metab 34:169-76. 2008.... - [International Prostate Symptom Scale. Evaluation of the usefulness of a French version]J Moisan
Faculté de pharmacie de l Université Laval, Que
Can Fam Physician 46:1772-6. 2000.... - Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviorsC M Morin
Ecole de Psychologie, Universite Laval, and Centre de recherche du CHA Hôpital du Saint Sacrement, Quebec City, Quebec, Canada
Sleep Med 7:123-30. 2006..To estimate the prevalence of insomnia symptoms and syndrome in the general population, describe the types of self-help treatments and consultations initiated for insomnia, and examine help-seeking determinants... - Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trialLucie Baillargeon
Department of Family Medicine, Laval University, Sainte Foy, Que
CMAJ 169:1015-20. 2003..We compared the efficacy of tapering plus cognitive-behavioural therapy for insomnia with tapering alone in reducing the use of hypnotics by older adults with insomnia... - Non-compliance with drug treatment and reading difficulties with regard to prescription labelling among seniorsJocelyne Moisan
Groupe de Recherche en Epidemiologie, Faculte de Pharmacie, Hopital du St Sacrement du CHA, Universite Laval, 1050 Chemin Ste Foy, Quebec, G1S 4L8 Canada
Gerontology 48:44-51. 2002..BACKGROUND; The link between experiencing difficulties in reading or understanding and non-compliance with drug treatment among seniors is not clearly established... - Ambulatory use of inhaled beta(2)-agonists for the treatment of asthma in Quebec : a population-based utilization reviewR Blais
Département d administration de la santé et Groupe de recherche interdisciplinaire en santé, Universite de Montreal, Montreal, Quebec, Canada
Chest 119:1316-21. 2001.... - Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidentsM Daley
Ecole de Psychologie, Universite Laval, Quebec, Canada G1K 0A6
Sleep Med 10:427-38. 2009..To document and provide a micro analysis of the relationship between insomnia and health problems, health-care use, absenteeism, productivity and accidents... - [Factors associated with short- and long-term use of benzodiazepines in the elderly from Quebec]Dany Fortin
Faculté de médecine de l Université de Sherbrooke et Centre de recherche sur le vieillissement de l Institut universitaire de geriatrie de Sherbrooke, 1036 rue Belvedere sud, Sherbrooke, QC, J1H 4C4, Canada
Can J Aging 24:103-13. 2005..In this study, we were unable to show a difference between the two groups of users with regards to the risk factors studied. This result leads us to conclude that prevention of long-term use must be aimed at all new benzodiazepine users... - Exploring the risk of diabetes mellitus and dyslipidemia among ambulatory users of atypical antipsychotics: a population-based comparison of risperidone and olanzapineJocelyne Moisan
Faculty of Pharmacy, , , Que, Canada
Pharmacoepidemiol Drug Saf 14:427-36. 2005..47 (1.23-1.76)]. CONCLUSIONS: Olanzapine seems to be associated with a higher risk of developing diabetes and/or dyslipidemia than risperidone. Further prospective studies are needed to rigorously assess the safety of olanzapine... - Social context, the struggle with uncertainty, and subjective risk as meaning-rich constructs for explaining HBP noncomplianceMichelle Proulx
Equipe sur le Médicament Comme Objet Social et Culturel MEOS, Faculte de Pharmacie, Universite de Montreal, Canada
Patient Educ Couns 68:98-106. 2007..To identify the reasons for which people fail to take blood-pressure-lowering medication regularly, a qualitative study was conducted... - Ambulatory use of olanzapine and risperidone: a population-based study on persistence and the use of concomitant therapy in the treatment of schizophreniaDan Cooper
, , Quebec City, Quebec
Can J Psychiatry 50:901-8. 2005..Among those who persisted, concomitant use of other antipsychotics did not differ between olanzapine users and risperidone users... - [Drug prescription practices in public medical centres in Gabon]Pamphile-Gervais Nkogho Mengue
, , , ,
Sante 15:229-34. 2005..Among other things, the prescription of drugs under their INN is very low. These findings highlight the need to develop and implement programs that seek to improve the quality of drug prescriptions in Gabon... - A pharmacy-based health promotion programme in hypertension: cost-benefit analysisIsabelle Côté
Faculty of Pharmacy, Laval University, Quebec, Canada
Pharmacoeconomics 21:415-28. 2003..This programme was developed to improve blood pressure control through activities aimed at improving the quality of prescribing and the adherence to treatment... - Determinants of discontinuation of new courses of antihypertensive medicationsJean Pierre Grégoire
Faculté de pharmacie and Unité de recherche en santé des populations, Universite Laval, Quebec, Canada
J Clin Epidemiol 55:728-35. 2002..74; 95% CI 0.55-0.99). Persistence with newly prescribed medications could be improved by selecting antihypertensive medications containing fewer side effects and by lifting economic barriers to drug treatment...